Rapid Communication

You have free access to this content

Genetic variation in a haplotype block spanning IDE influences Alzheimer disease†

  1. Jonathan A. Prince1,
  2. Lars Feuk1,
  3. Harvest F. Gu1,
  4. Boo Johansson2,
  5. Margaret Gatz3,
  6. Kaj Blennow4,
  7. Anthony J. Brookes1,*

Article first published online: 24 SEP 2003

DOI: 10.1002/humu.10282

Issue

Human Mutation

Human Mutation

Volume 22, Issue 5, pages 363–371, November 2003

Additional Information

How to Cite

Prince, J. A., Feuk, L., Gu, H. F., Johansson, B., Gatz, M., Blennow, K. and Brookes, A. J. (2003), Genetic variation in a haplotype block spanning IDE influences Alzheimer disease. Hum. Mutat., 22: 363–371. doi: 10.1002/humu.10282

Author Information

  1. 1

    Center for Genomics and Bioinformatics, Karolinska Institute, Stockholm, Sweden

  2. 2

    Department of Psychology, University of Göteborg, Göteborg, Sweden

  3. 3

    Department of Psychology, University of Southern California, Los Angeles, California

  4. 4

    Department of Clinical Neuroscience and Transfusion Medicine, University of Göteborg, Sahlgren's University Hospital, Göteborg, Sweden

*Center for Genomics and Bioinformatics, Karolinska Institute, Berzelius väg 35, S-171 77 Stockholm, Sweden

  1. †

    Communicated by Richard G. H. Cotton

Publication History

  1. Issue published online: 25 SEP 2003
  2. Article first published online: 24 SEP 2003
  3. Manuscript Accepted: 29 AUG 2003
  4. Manuscript Received: 11 AUG 2003

Funded by

  • Pharmacia Corporation
  • Swedish Medical Research Council
  • Swedish Foundation for Strategic Research
  • Knut and Alice Wallenberg Foundation
  • AMF Jubileum Fund
  • Tore Nilsons Foundation
  • Loo and Hans Ostermans Foundation
  • Swedish Old Servants Foundation (Gamla Tjänarinnor)
  • Captain Arthur Erikssons Foundation
  • Åke Wibergs Foundation
  • Torsten and Ragnar Söderbergs Foundation
  • Fredrik and Ingrid Thurings Foundation
  • Swedish Alzheimer Foundation (Alzheimerfonden)
  • NIA. Grant Numbers: R01-AG08724, AG08861

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (186K)

REFERENCES

  • Abraham R, Myers A, Wavrant-DeVrieze F, Hamshere ML, Thomas HV, Marshall H, Compton D, Spurlock G, Turic D, Hoogendoorn B, Kwon JM, Petersen RC, Tangalos E, Norton J, Morris JC, Bullock R, Liolitsa D, Lovestone S, Hardy J, Goate A, O'Donovan M, Williams J, Owen MJ, Jones L. 2001. Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet 109:646–652.
  • Ait-Ghezala G, Abdullah L, Crescentini R, Crawford F, Town T, Singh S, Richards D, Duara R, Mullan M. 2002. Confirmation of association between D10S583 and Alzheimer's disease in a case—control sample. Neurosci Lett 325:87–90.
  • Alafuzoff I, Iqbal K, Fridén H, Adolfsson R, Winblad B. 1987. Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol 74:209–225.
  • Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, Yhu S, McInnis MG, Go RC, Vekrellis K, Selkoe DJ, Saunders AJ, Tanzi RE. 2000. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290:2302–2303.
  • Boussaha M, Hannequin D, Verpillat P, Brice A, Frebourg T, Campion D. 2002. Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease. Neurosci Lett 329:121–123.
  • Edbauer D, Willem M, Lammich S, Steiner H, Haass C. 2002. Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). J Biol Chem 277:13389–13393.
  • Edland SD, Wavrant-De Vriese F, Compton D, Smith GE, Ivnik R, Boeve BF, Tangalos EG, Petersen RC. 2003. Insulin degrading enzyme (IDE) genetic variants and risk of Alzheimer's disease: evidence of effect modification by apolipoprotein E (APOE). Neurosci Lett 345:21–24.
  • Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin SG. 2000. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290:2303–2304.
  • Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S. 2003. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100:4162–4167.
  • Fredman D, Siegfried M, Yuan YP, Bork P, Lehvaslaiho H, Brookes AJ. 2002. HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources. Nucleic Acids Res 30:387–391.
  • Gatz M, Pedersen NL, Berg S, Johansson B, Johansson K, Mortimer JA, Posner SF, Viitanen M, Winblad B, Ahlbom A. 1997. Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci 52:M117–M125.
  • Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M, Hardy J. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704–706.
  • Howell WM, Jobs M, Brookes AJ. 2002. iFRET: an improved fluorescence system for DNA melting analysis. Genome Res 12:1401–1407.
  • Jobs M, Howell WM, Strömqvist L, Brookes AJ. 2003. DASH-2: flexible, low-cost and high-throughput SNP genotyping by dynamic allele-specific hybridization on membrane arrays. Genome Res 13:916–924.
  • Karamohamed S, Demissie S, Volcjak J, Liu C, Heard-Costa N, Liu J, Shoemaker CM, Panhuysen CI, Meigs JB, Wilson P, Atwood LD, Cupples LA, Herbert Framingham Heart Study. 2003. Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes 52:1562–1567.
  • Lee C. 2002. Irresistible force meets immovable object: SNP mapping of complex diseases. Trends Genet 18:67–69.
  • Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen FA Jr, Goetz CG, Mastaglia F, Stajich JM, Gibson RA, Middleton LT, Saunders AM, Scott BL, Small GW, Nicodemus KK, Reed AD, Schmechel DE, Welsh-Bohmer KA, Conneally PM, Roses AD, Gilbert JR, Vance JM, Haines JL, Pericak-Vance MA. 2002. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70:985–993.
  • Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, Eckman CB, Hersh LB, Thiele DL. 2003. Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 100:6221–6226.
  • Myers A, Holmans P, Marshall H, Kwon J, Meyer D, Ramic D, Shears S, Booth J, DeVrieze FW, Crook R, Hamshere M, Abraham R, Tunstall N, Rice F, Carty S, Lillystone S, Kehoe P, Rudrasingham V, Jones L, Lovestone S, Perez-Tur J, Williams J, Owen MJ, Hardy J, Goate AM. 2000. Susceptibility locus for Alzheimer's disease on chromosome 10. Science 290:2304–2305.
  • Niu T, Qin ZS, Xu X, Liu JS. 2002. Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am J Hum Genet 70:157–169.
  • Prince JA, Feuk L, Howell WM, Jobs M, Emahazion T, Blennow K, Brookes AJ. 2001. Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res 11:152–162.
  • Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR, Safavi A, Hersh LB, Selkoe DJ. 1998. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273:32730–32738.
  • Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, Mar L, Sorbi S, Nacmias B, Piacentini S, Chumakov I, Cohen D, Lannfelt L, Fraser PE, Rommens JM, St. George-Hyslop PH. 1995. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376:775–778.
  • Schork NJ, Nath SK, Fallin D, Chakravarti A. 2000. Linkage disequilibrium analysis of biallelic DNA markers, human quantitative trait loci, and threshold-defined case and control subjects. Am J Hum Genet 67:1208–1218.
  • Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St. George-Hyslop PH. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754–760.
  • Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977–1981.
  • Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, Rosner MR, Selkoe DJ. 2000. Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20:1657–1665.
  • Warwick Daw E, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, Wijsman EM. 2000. The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66:196–204.
  • Woodburn K, Johnstone E. 1999. Ascertainment of a population of people with early-onset dementia in Lothian, Scotland. Int J Geriatr Psychiatry 14:362–367.
    Direct Link:
Get PDF (186K)